Ventas Inc

Ventas Inc(VTR)股票分析

$85.860

+1.013 (+1.18%)收盤時

Loading chart…
最高
86.040
開盤
85.100
成交量加權均價
85.49
成交量
3.85M
市值
20.57B
最低
84.555
成交金額
329.49M
企業價值/稅息折舊攤銷前利潤(TTM)
21.84

Ventas, Inc. is a real estate investment trust (REIT). The Company holds a portfolio that includes senior housing communities, outpatient medical buildings, research centers, hospitals and healthcare facilities located in North America and the United Kingdom. The Company owns approximately 1,450 properties in North America and the United Kingdom. It operates in three segments: senior housing operating portfolio (SHOP), outpatient medical and research portfolio (OM&R), and triple-net leased properties (NNN). In its SHOP segment, it owns and invests in senior housing communities. It engages third-party managers to operate the communities on its behalf. In its OM&R segment, it primarily acquires, owns, develops, leases and manages outpatient medical buildings and research centers. In its NNN segment, it invests in and owns senior housing communities, skilled nursing facilities (SNFs), long-term acute care facilities (LTACs), and freestanding inpatient rehabilitation facilities (IRFs).

AI 分析 of Ventas Inc (VTR)

持有

Ventas Inc is currently priced at $82.04, which is below several analyst price targets, including $100 from Evercore ISI and $102 from Jefferies, indicating potential upside. However, the RSI is at 37.426, suggesting the stock is oversold, and the recent 5-day change is -2.34%, indicating a downward trend. The main risk is the high forward P/E ratio of 128.2051, which suggests that the stock may be overvalued relative to its earnings potential.

分析師評級(20)

-1.92% 下跌空間
持有
2 買進
14 持有
4 賣出
目前: 85.86
最低
74.00
平均
84.21
最高
93.00

Evercore ISI

2026-09-21

目標價

$100

優於大盤

Jefferies

2026-09-15

目標價

$102

買進

Scotiabank

2026-09-02

目標價

$95

Sector Perform

Wells Fargo

2026-09-01

目標價

$104

增持

Barclays

2026-08-31

目標價

$102

Equal Weight

估值指標

Ventas Inc(VTR)目前預期本益比為 128.21,5 年平均預期本益比為 -489.97。

預期本益比

合理
5 年均值 P/E
-489.97
目前P/E
128.21
高估
2371.66
低估
-3351.60

預期 EV/EBITDA

高估
5 年均值 EV/EBITDA
18.98
目前EV/EBITDA
21.84
高估
20.96
低估
17.00

預期股價營收比

高估
5 年均值 P/S
4.79
目前P/S
5.61
高估
5.52
低估
4.06

Alphio AI 對 VTR 的價格情境

情境價格取自當年最後一個月度預測區間。機率為固定的模型權重(25 / 50 / 25),不構成保證。

樂

樂觀

樂觀 · 25%VTR

$86.84

情境價格

基

基準

基準 · 50%VTR

$81.18

情境價格

悲

悲觀

悲觀 · 25%VTR

$78.25

情境價格

持有 VTR 的大戶

K

KGI Securities Investment Trust Co., Ltd.

+ 持有VTR

+3.03%

3個月報酬率

N

New Age Alpha Advisors, LLC

+ 持有VTR

+2.57%

3個月報酬率

L

Los Angeles Capital Management LLC

+ 持有VTR

+2.36%

3個月報酬率

S

Stichting Pensioenfonds ABP

+ 持有VTR

+2.20%

3個月報酬率

P

Principal Global Investors, LLC

+ 持有VTR

+1.66%

3個月報酬率

P

Pallas Capital Advisors LLC

+ 持有VTR

+0.72%

3個月報酬率

VTR 常見問題 —— 由 Alphio AI 解答

Ventas, Inc. is a real estate investment trust (REIT). The Company holds a portfolio that includes senior housing communities, outpatient medical buildings, research centers, hospitals and healthcare facilities located in North America and the United Kingdom. The Company owns approximately 1,450 properties in North America and the United Kingdom. It operates in three segments: senior housing operating portfolio (SHOP), outpatient medical and research portfolio (OM&R), and triple-net leased properties (NNN). In its SHOP segment, it owns and invests in senior housing communities. It engages third-party managers to operate the communities on its behalf. In its OM&R segment, it primarily acquires, owns, develops, leases and manages outpatient medical buildings and research centers. In its NNN segment, it invests in and owns senior housing communities, skilled nursing facilities (SNFs), long-term acute care facilities (LTACs), and freestanding inpatient rehabilitation facilities (IRFs). It operates in the Real Estate sector (REAL ESTATE INVESTMENT TRUSTS industry).

Ventas Inc is currently priced at $82.04, which is below several analyst price targets, including $100 from Evercore ISI and $102 from Jefferies, indicating potential upside. However, the RSI is at 37.426, suggesting the stock is oversold, and the recent 5-day change is -2.34%, indicating a downward trend. The main risk is the high forward P/E ratio of 128.2051, which suggests that the stock may be overvalued relative to its earnings potential.

20 analysts cover VTR: 2 rate it Buy, 14 Hold and 4 Sell. The average price target is 84.21.

暫無貼文

註冊或登入後參與討論

本頁僅供研究參考,不構成投資建議。模型可能出錯。過往表現不代表未來結果。

開始交易